Emergent BioSolutions Inc. (LON:0IGA)

Emergent BioSolutions Statistics

Total Valuation

LON:0IGA has a market cap or net worth of GBP 387.81 million. The enterprise value is 694.47 million.

Market Cap	387.81M
Enterprise Value	694.47M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	53.35M
Shares Outstanding	n/a
Shares Change (YoY)	+5.75%
Shares Change (QoQ)	-5.41%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	67.90%
Float	51.91M

Valuation Ratios

The trailing PE ratio is 3.81 and the forward PE ratio is 21.65.

PE Ratio	3.81
Forward PE	21.65
PS Ratio	0.62
PB Ratio	0.99
P/TBV Ratio	7.91
P/FCF Ratio	3.43
P/OCF Ratio	3.14
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.27, with an EV/FCF ratio of 6.14.

EV / Earnings	6.82
EV / Sales	1.09
EV / EBITDA	4.27
EV / EBIT	7.85
EV / FCF	6.14

Financial Position

The company has a current ratio of 5.66, with a Debt / Equity ratio of 1.26.

Current Ratio	5.66
Quick Ratio	2.73
Debt / Equity	1.26
Debt / EBITDA	3.12
Debt / FCF	4.36
Interest Coverage	2.25

Financial Efficiency

Return on equity (ROE) is 30.24% and return on invested capital (ROIC) is 5.96%.

Return on Equity (ROE)	30.24%
Return on Assets (ROA)	5.03%
Return on Invested Capital (ROIC)	5.96%
Return on Capital Employed (ROCE)	9.15%
Revenue Per Employee	690,648
Profits Per Employee	113,135
Employee Count	900
Asset Turnover	0.58
Inventory Turnover	1.13

Taxes

In the past 12 months, LON:0IGA has paid 37.37 million in taxes.

Income Tax	37.37M
Effective Tax Rate	26.85%

Stock Price Statistics

The stock price has increased by +10.12% in the last 52 weeks. The beta is 2.05, so LON:0IGA's price volatility has been higher than the market average.

Beta (5Y)	2.05
52-Week Price Change	+10.12%
50-Day Moving Average	8.84
200-Day Moving Average	7.43
Relative Strength Index (RSI)	56.55
Average Volume (20 Days)	4,579

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.01

Income Statement

In the last 12 months, LON:0IGA had revenue of GBP 621.58 million and earned 101.82 million in profits. Earnings per share was 1.84.

Revenue	621.58M
Gross Profit	350.50M
Operating Income	86.13M
Pretax Income	139.19M
Net Income	101.82M
EBITDA	158.24M
EBIT	86.13M
Earnings Per Share (EPS)	1.84

Balance Sheet

The company has 195.10 million in cash and 493.49 million in debt, giving a net cash position of -298.38 million.

Cash & Cash Equivalents	195.10M
Total Debt	493.49M
Net Cash	-298.38M
Net Cash Per Share	n/a
Equity (Book Value)	391.37M
Book Value Per Share	7.29
Working Capital	432.39M

Cash Flow

In the last 12 months, operating cash flow was 123.35 million and capital expenditures -10.22 million, giving a free cash flow of 113.13 million.

Operating Cash Flow	123.35M
Capital Expenditures	-10.22M
Free Cash Flow	113.13M
FCF Per Share	n/a

Margins

Gross margin is 56.39%, with operating and profit margins of 13.86% and 16.38%.

Gross Margin	56.39%
Operating Margin	13.86%
Pretax Margin	22.39%
Profit Margin	16.38%
EBITDA Margin	25.46%
EBIT Margin	13.86%
FCF Margin	18.20%

Dividends & Yields

LON:0IGA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.75%
Shareholder Yield	-5.75%
Earnings Yield	26.26%
FCF Yield	29.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0IGA has an Altman Z-Score of 1.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.52
Piotroski F-Score	6